The tolerance of reirradiation and hyperthermia in breast cancer patients with reconstructions

Marianne Linthorst, Gerard van Rhoon, AN Geel, M Baaijens, W Ghidey, MP Broekmeyer-Reurink, Cobi Zee

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)


Background: Breast cancer recurrences in previously irradiated areas are treated with reirradiation (reRT) and hyperthermia (HT). The aim of this retrospective study is to quantify the toxicity of HT in breast cancer patients with reconstruction. Methods: Between 1992 and 2009, 36 patients were treated with reRT with a scheme of 8 fractions of 4.0 Gy in 4 weeks, and HT on a total of 37 tissue reconstructions. The types of reconstructions were: split-thickness skin graft (15), transverse rectus abdominis myocutaneous flap (1), latissimus dorsi flap (14), rhomboid flap (1) or a combination of grafts and flaps (6). Toxicities were graded according to the Common Terminology Criteria for Adverse Events (CTCAE), version 3.0. Patient, tumour, a Results: The median follow-up time was 64 months. Grade 2 HT toxicity occurred in four patients and grade 3 in three. The three patients with grade 3 HT toxicity required reoperation. None of the evaluated parameters showed a significant relationship with HT toxicity. The CR rate in 15 patients with macroscopic disease was 80%. The 3 and 5 year LC rates were 74% and 69%; the median OS was 55 months. Conclusions: Combined reRT and HT in breast cancer patients with reconstruction is safe and effective.
Original languageUndefined/Unknown
Pages (from-to)267-277
Number of pages11
JournalInternational Journal of Hyperthermia
Issue number3
Publication statusPublished - 2012

Research programs

  • EMC MM-03-32-05

Cite this